PB Fintech shares were trading at ₹1,160.30 on the NSE at around 1 pm, with Bernstein's target price of ₹2,310 implying a potential upside of about 99%. The global brokerage maintained its 'Outperform' rating on the Policybazaar parent despite projecting a sharp earnings hit from the proposed changes to insurance distribution rules. Bernstein estimates that the draft regulatory framework could result in an approximately 38% hit to PB Fintech's FY30 estimated bottom line, with FY30 profit at around ₹20 billion (₹2,000 crore) compared with its pre-regulation estimate of ₹32 billion (₹3,200 crore). The brokerage now sees FY28 profit at around ₹11 billion (₹1,100 crore), which would be 34% lower under the regulatory scenario, versus its FY27 PAT estimate of ₹12.5 billion (₹1,250 crore).
Bernstein estimates that the proposed regulatory framework could result in a 40% reduction in insurance take rates, potentially cutting PB Fintech's FY28E profit by around 34% to approximately ₹1,100 crore under their scenario, versus ₹1,250 crore in FY27. The brokerage estimates PB Fintech's FY28E profit at ₹1,100 crore, below its FY27E PAT estimate of ₹1,250 crore, despite cost-control measures. The proposed framework could translate into a potential 36% cut in FY28E consolidated revenue, with Paisabazaar cushioning some of the impact. PB Fintech hosted a call to discuss the implications of the IRDAI's proposal and indicated that the changes, if implemented, could result in a potential 30% hit to FY28 core online insurance revenue. The shift in term plans towards a trial-based structure could also defer cash flows, creating an initial working-capital drag. HSBC analysts noted that the proposed distribution reforms, including commission caps, could have a material impact on PB Fintech, while regulatory clarity on the final framework would be a key catalyst for the stock.
Ambit Capital sees potential benefits for Policybazaar from the relative impact on competing distribution channels, noting that lower commissions could hurt higher upfront commission-led channels more severely, potentially making Policybazaar more attractive to insurers. The brokerage noted that the platform currently has around 20% market share in retail health and about 25% in term life, with health insurance facing the sharpest pressure under the proposed framework. "The proposed sharp commission cuts could hurt higher upfront commission-led channels more, especially agents in health and banks/NBFCs in life, improving PB's channel attractiveness and aiding market-share shift to PB," Ambit said. BofA's analysis shows that the platform is becoming less dependent on a small group of insurers, with United India Insurance, Axis Max Life and Niva Bupa among the larger contributors across general, life and health insurance. The brokerage also expects any benefit from lower customer pricing or reduced advertising costs to take time to emerge, with greater customer pull potentially helping Policybazaar reduce its advertising burden, which currently accounts for around 25-30% of its revenue.
BofA's latest analysis points to a broader revenue base for Policybazaar, with life insurers contributing less than a third of revenue compared to more than 60% in FY22, while general insurance accounts for 48% and standalone health insurers for 21%. The brokerage estimates renewal premiums could grow at a 39% CAGR between FY26 and FY29, compared with 29% for new business, with the improving renewal mix supporting profitability because renewal business carries lower acquisition and selling costs. BofA also sees renewals becoming increasingly important to the business, with the improving renewal mix supporting long-term profitability. The brokerage is tracking the expansion of PB Partners, international operations and reinsurance broking, with reinsurance broking seen as a fee-based adjacent business that can use PB Fintech's insurance ecosystem and data without taking underwriting risk. PB Fintech's core platform expenses, excluding employee stock ownership plan (ESOP) costs, stood at nearly ₹3,000 crore in FY26, with around 80% being variable.
The IRDAI proposals are currently at the consultation stage, meaning their eventual impact on PB Fintech will depend on the final regulations and the steps taken by the company to adapt its business model. Among the proposals is a crackdown on so-called 'dark patterns' used on insurance websites, with the regulator proposing to restrict practices that require customers to provide personal information before viewing key product features or pricing details. Bernstein sees potential for PB Fintech to explore alternative models for its health insurance business, including asset-light options such as a Managing General Agent (MGA) model and an insurance Certificate of Registration (CoR). The brokerage also sees room for PB Fintech to adjust its cost structure, with management seeing scope to rationalise expenses such as call-centre hiring and variable payouts as it adapts to the proposed regulatory framework. From FY29 onwards, Bernstein expects growth and margin expansion to resume, albeit from a lower earnings base.
